Stock Events

Stock Events

Taysha Gene Therapies (TSHA) Q1 2026 Earnings

19MarConfirmed

Q2 2025

Q3 2025

Q4 2025

Q1 2026

-0.1

-0.09

-0.08

-0.08

Details

Expected EPS

-0.095607

Actual EPS

-0.08

Surprise EPS

0.02

Surprise Percent

+16.32%

Description

Taysha Gene Therapies (TSHA) has reported earnings of -0.08 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.